Article
Catalent sees weight-loss drugs boom driving bookings until FY 2026
Rating:
0.0
Views:
32
Likes:
1
Library:
1
Catalent said on Wednesday it expected a majority of its current and upcoming production capacity for pre-filled syringes until fiscal year 2026 to soon be booked out, driven by booming demand for newer weight-loss drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value